Free Trial

Govt May not Receive AstraZeneca Vaccine as Promised; Tax Expert Highlights Budget Risks

SOUTH AFRICA

LOCAL NEWS

  • Astrazeneca says it cannot sell vaccines in SA as it does not hold rights to make the sale, despite Govt claims of being in talks for 1.5m doses for months.
  • Its vaccine is among the cheapest on the market and could put upside pressure on the expected R20bn cost of vaccine purchases & delay the rollout - News24
  • Tax expert warns Alcohol ban is costing SA Revenue Services (SARS) R2.5bn/month in lost revenue which should translate into a larger revenue miss than was already expected at ~312.8bn, boosting the budget deficit to around 14.6-15% at the Feb Budget - MoneyWeb
  • Covid cases continue to decline showing early signs of peaking, now at 13,105/day, but 755 deaths - Business Tech
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.